U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again ...

Stifel Financial downgraded Zoetis stock on Wednesday, causing the animal health company’s shares to fall 4% on the news. The ...

Zoetis was created in 2013 after splitting off from Pfizer’s animal health division. While it may not seem like a household ...

Infosys has announced a strategic partnership with Zoetis to enhance the latter's IT operations using AI and automation. This ...

Infosys announced a strategic collaboration with Zoetis, the world's leading animal health company. This long-term engagement aims to enhance Zoetis' IT operations and digital capabilities by ...

The generic drug contains cefovecin sodium, the same active ingredient as Convenia (Zoetis), which was approved by the FDA in ...

Nick Jorgensen breaks down how genomics testing helps cattle producers select better heifers, manage risk, reduce bull ...

Zoetis Inc. closed 19.30% below its 52-week high of $200.33, which the company achieved on September 19th.

Fintel reports that on June 18, 2025, Stifel downgraded their outlook for Zoetis (NYSE:ZTS) from Buy to Hold. Analyst Price ...

Zoetis Inc. closed 17.97% short of its 52-week high of $200.33, which the company reached on September 19th.

Stocks including Tata Motors, Infosys, Arisinfra, Hindalco, Timex Group, Auro Pharma, RITES, Kaynes Technology, JB Chem & ...